ODDB.org: Open Drug Database

Bristol-Myers Squibb SA - Imnovid 3 mg, Hartkapseln

Swissmedic Registration	61249	Sequence	03
Product name	Imnovid 3 mg	Description	Hartkapseln
ATC-Classification	L04AX06	ATC-Description	Pomalidomide
Introduction of Sequence	02.06.2014

Composition

pomalidomidum 3 mg, mannitolum, amylum pregelificatum, natrii stearylis fumaras corresp. natrium 0.025 mg, Kapselhülle: gelatina, E 171, E 132, E 172 (flavum), Drucktinte: lacca, E 171, simeticonum, propylenglycolum, ammoniae solutio 28 per centum, pro capsula.

Packungsbestandteile

Galenic Form

Capsules

Active Agent	Dose
Pomalidomidum	3 mg

BAG: Active Agent	Dose
Pomalidomidum	3 mg

Inactive agents	Dose	additional_information
(Flavum)
Ammoniae Solutio	28
Amylum Pregelificatum
E 132		color.
E 171		color.
E 172		color.
Gelatina		Kapselhülle
Lacca		Drucktinte
Mannitol
Natrii Stearylis Fumaras
Per Centum
Pro Capsula
Propylenglycol
Simeticone

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
003	21 Capsule(s)	8018.03	8440.35	A	SL	Yes
007	14	PR	PR	A		Yes

2025	©ywesee GmbH